469 Angiogenesis gene variants as biomarkers for bevacizumab-induced toxicities: a translational sub...
469 Angiogenesis gene variants as biomarkers for bevacizumab-induced toxicities: a translational subproject of the prospective randomized phase III trial AGO-OVAR 17
About this item
Full title
Author / Creator
Polaczek, Rahel , Heitz, Florian , Ramachandran, Dhanya , Hillemanns, Peter , Rau, Jörn , Harter, Philipp , Heubner, Martin L , Canzler, Ulrich , Jackisch, Christian , Baumann, Klaus , Schmalfeldt, Barbara , Burges, Alexander , Ch Hanker, Lars , Hartkopf, Andreas D , Park-Simon, Tjoung-Won , Belau, Antje , Denschlag, Dominik , Schröder, Willibald , Dörk, Thilo and Pfisterer, Jacobus
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundBevacizumab is a monoclonal antibody against soluble VEGF, active in the treatment of various cancer entities and one standard in the primary treatment of patients with advanced ovarian cancer. Toxicity profile of bevacizumab is favorable, however, hypertension and renal toxicites are specific side effects, which might lead t...
Alternative Titles
Full title
469 Angiogenesis gene variants as biomarkers for bevacizumab-induced toxicities: a translational subproject of the prospective randomized phase III trial AGO-OVAR 17
Authors, Artists and Contributors
Author / Creator
Heitz, Florian
Ramachandran, Dhanya
Hillemanns, Peter
Rau, Jörn
Harter, Philipp
Heubner, Martin L
Canzler, Ulrich
Jackisch, Christian
Baumann, Klaus
Schmalfeldt, Barbara
Burges, Alexander
Ch Hanker, Lars
Hartkopf, Andreas D
Park-Simon, Tjoung-Won
Belau, Antje
Denschlag, Dominik
Schröder, Willibald
Dörk, Thilo
Pfisterer, Jacobus
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2954869303
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2954869303
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2024-ESGO.977
